Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat

By Kuzumoto Y.   Kusunoki S.   Kato N.   Kihara M.   Low P.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3085-3093

Springer Publishing Company

Access to resources Recommend Favorite

Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-09 ,pp. : 234-240

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review

By  

Current Diabetes Reviews, Vol. 9, Iss. 3, 2013-05 ,pp. : 249-266

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Therapies for Diabetic Neuropathy: A Clinical Overview

By  

Current Diabetes Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor

By Calcutt N.   Freshwater J.   Mizisin A.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 718-724

Springer Publishing Company

Access to resources Recommend Favorite